The story of streptomycin runs deep into the trenches of medical history. In the 1940s, scientists chased a miracle for tuberculosis. Albert Schatz, working in Selman Waksman’s lab, uncovered streptomycin in a soil sample—a development that pushed antibiotics into a new era. Penicillin had already dazzled the world, but tuberculosis kept killing. Streptomycin didn’t just help beat TB; it cracked open the bacteria behind the disease, which made it possible to save millions of lives. The world’s first antibiotic effective against Mycobacterium tuberculosis, it paved the way for combination therapies that people around the world still depend on. Because of this, streptomycin sits as the foundation for discussions about new antibiotics and resistance today.
Streptomycin sulfate appears as a white, water-soluble powder. It comes from the actinomycete Streptomyces griseus, a soil-dwelling microbe. Manufacturers sell it as a fine powder or lyophilized cake. From day one, pharmaceutical companies distributed it for injection, mostly to treat tuberculosis, brucellosis, and, at times, infections in people allergic to penicillin. Veterinary medicine relies on it, too; breeders use it in livestock and aquaculture to hold back a range of bacterial infections.
The white powder dissolves readily in water, smells faintly musty, and tastes bitter. It won’t blend with most organic solvents. Streptomycin forms a sulfate salt with the formula C21H39N7O12·3.5H2SO4. Its molecule boasts multiple amine and hydroxyl groups, giving it strong ionic character. It needs to be kept cool, dry, and away from light. Streptomycin breaks down if it’s exposed to air, light, or moisture for too long, and anybody who’s worked in a veterinary pharmacy or a hospital storeroom has seen how critical it is to keep it sealed.
When you pick up a product insert, you’ll spot detailed labeling requirements set by pharmacopoeias in the US, Europe, and beyond. Labels spell out purity grades, potency (in International Units, usually 1g equals about 1,000,000 IU), pH range, heavy metal content, microbial limits, and recommended storage at 2–8°C. The specs permit only trace contaminants, since any remaining fermentation residues or breakdown products could trigger allergic or toxic responses. Labeling addresses route of administration—intramuscular and intravenous use remain most common—plus clear warnings about kidney toxicity and hearing damage, two real-world risks for folks on streptomycin therapy.
Traditional production relies on fermenting Streptomyces griseus in nutrient broths with added soybean meal or glucose. Inside massive fermenters, operators tweak temperature and aeration, harvesting the antibiotic after a few days. Extraction involves filtration, carbon treatment to remove color, and precipitation as a sulfate salt. Later stages include vacuum drying, milling, and sterile packaging. Many companies enhance yields with better strain selection or genetic tweaks, and some tap downstream processing tech—such as ultrafiltration—to refine and purify the product before it ships. Most fermentation plants now monitor parameters in real time with digital controls, a far cry from the guesswork that ruled in the 1940s.
Streptomycin’s structure offers plenty of points for chemical reactions. The molecule undergoes acid hydrolysis, splitting into streptidine, streptose, and N-methyl-L-glucosamine, which gives chemists room to modify it when necessary. Derivatives sometimes arise when seeking improved pharmacological properties or lower toxicity, but these modifications often reduce antimicrobial punch. Early research explored semi-synthetic variants hoping for more stability or less kidney damage, but the original sulfate salt still dominates medicine cabinets and livestock barns.
Doctors and scientists recognize streptomycin sulfate under a handful of names: Streptomycinum Sulfuricum, SM, Streptomycin monosulfate, Streptomycin dihydrogen sulfate, and sometimes by trade names like Streptomycin A or Streptomycine. In the field and on the shop floor, veterinarians and pharmacists abbreviate it as “Strepto,” and suppliers across continents import and sell the compound under these trade names, ensuring that language differences pose little problem for prescribers and patients.
Many folks in medicine and agriculture have learned streptomycin’s double-edged nature. On one hand, it conquered infections that nothing else could touch. On the other, its use comes with stiff safety rules. Operating standards call for protective gear to keep powders off the skin and out of the lungs. In clinics, routine clinical monitoring tracks kidney and hearing function, since ototoxicity and nephrotoxicity remain leading concerns. Waste from fermentation plants can’t go straight down the drain; for years, environmental officers have pushed manufacturers to treat effluent and control bioaerosol emissions.
Streptomycin earned its fame saving TB patients. Today’s prescribers still use it against mycobacterial infections—especially when first-line drugs can’t win or allergies crop up. It’s found work in treating plague, tularemia, and brucellosis. Some lower-resource countries keep it on hand for resistant enteric pathogens. In the fields, commercial apple and pear growers spray it to keep fire blight at bay, though rising resistance means many now limit its use. For veterinarians and fish farmers, it keeps livestock and aquaculture healthy, with major economic savings. Clinics and supply distributors need to balance access with stewardship, knowing that bacteria develop resistance if dosage patterns aren’t carefully managed.
Pharmaceutical R&D teams constantly search for ways to optimize old antibiotics, and streptomycin attracts attention as a model aminoglycoside. Some labs engineer new fermentation strains to improve outputs and cut production costs. Researchers probe its mechanism, studying how it binds to bacterial ribosomes and blocks protein synthesis. For those of us in the field, these insights matter—a deep understanding of resistance mechanisms guides how doctors rotate antibiotics in care guidelines. Recently, researchers have started to explore new delivery routes, targeting formulations that deposit streptomycin where needed and keep systemic exposure to a minimum. Bioinformatics and synthetic biology open fresh doors, letting teams design analogs or produce hybrid molecules with broader action and lower toxicity.
Experience teaches that while streptomycin saves lives, it isn’t risk-free. Decades of studies detail its toxic effects—primarily nephrotoxicity and ototoxicity. High doses or prolonged use may damage the kidneys or the hearing nerve. Some reports connect repeated veterinary use with environmental buildup, leading to sensitive species in streams and soil showing stress. Preclinical research in animals guides safe dosing in humans and large animals by mapping out exactly how the compound is absorbed, metabolized, and excreted. Lab tests now track genetic markers of risk, aiming to predict who faces hearing loss after treatment. This information arms doctors and veterinarians with sharper guidelines and helps set policy for environmental protection.
Antibiotic resistance looms as a challenge across the globe. Streptomycin’s effectiveness dips as bacteria evolve, but innovation offers hope. New diagnostic tools are on the horizon, letting doctors quickly match drugs to bugs, which reduces wasted doses and cuts the path to resistance. Researchers think about smart packaging and digital pill-tracking to support adherence and monitoring. Synthetic biology holds promise, with engineered microbes poised to boost purity, cut unwanted byproducts, and maybe deliver variants against modern superbugs. Public health agencies call for a careful balance—preserve old antibiotics like streptomycin, but keep pushing for new ones. Their message echoes in every hospital and farm: stewardship matters, innovation can’t stall, and the world’s lessons from the streptomycin era should guide future discovery.
Streptomycin sulfate makes its mark as a reliable antibiotic, especially in cases where other antibiotics fall short. Discovered in the 1940s from soil bacteria, it quickly found a spot in the fight against tuberculosis. Mycobacterium tuberculosis, the culprit behind TB, once terrified families all over the world. Doctors leaned on streptomycin when penicillin couldn’t help. Streptomycin’s effectiveness targets bacteria that have a tough outer shell and dodge simpler antibiotics. My grandmother’s generation talked about TB sanatoriums and the quiet fear lingering in communities. So many lives changed when streptomycin entered the medical field and offered hope to those wasting away in those hospitals.
This antibiotic also steps in to treat infections caused by gram-negative bacteria—think plague (yes, the actual plague, Yersinia pestis), tularemia, and certain types of bacterial endocarditis. Veterans of World War II remember soldiers who owed their survival to this simple powder. In some countries where plague still flares up, health workers stack up on streptomycin to save villages from becoming statistics. Its application doesn’t stop at humans; veterinarians depend on it for respiratory or uterine infections in cattle and pigs, and fish farmers sometimes use it to control bacterial outbreaks in aquaculture.
Streptomycin interferes with a bacterium's ability to produce proteins, which eventually kills the bacteria. It binds to the bacterial ribosome and messes with protein synthesis. Bacteria fall apart without their proteins, sort of like an orchestra losing its musicians. Doctors have to be careful, though, because streptomycin can also affect the cells in our ears and kidneys. My uncle, who loved to tinker with radios, once compared these side effects to “crossed wires”—essential functions affected by an outside influence. This is why doctors monitor patients for hearing loss and changes in kidney function. You hear stories on hospital wards about folks who can’t hear so well after a few rounds of antibiotics. Streptomycin stands as a classic example of medicine’s double-edged sword: life-saving, but not without price.
Antibiotic resistance always creeps up in the conversation. I’ve seen friends pick up antibiotics at the first hint of a sore throat, expecting a fast fix. Over time, smart bacteria figure out how to dodge these drugs. These resistant bugs make each infection that much more dangerous. The Centers for Disease Control and Prevention tracks growing resistance and recommends reserving streptomycin for cases with no better option. This means finishing prescribed courses and not using leftover pills from the medicine cabinet. Those little choices save lives—maybe not today, but someday.
Doctors, scientists, and public health experts push for new antibiotics and creative treatments every year. Funding often falls short. Hospitals can encourage stewardship programs: tracking which antibiotics get prescribed, training doctors, and easing reliance on older drugs like streptomycin. In rural clinics around the world, even simple tools—charts or phone apps to check for resistance patterns—help guide decisions. Building basic lab capacity to identify bacteria, not just treat symptoms, marks progress. It’s a group effort, blending science, old-fashioned common sense, and community trust. Streptomycin remains part of our medicine cabinet, but only if we use it wisely.
Streptomycin sulfate isn’t your average household medicine. We’re talking about a potent antibiotic, used in some of the roughest infection cases in medicine. Safe storage doesn’t just keep it usable — it protects patients. Anyone who’s ever worked in a pharmacy, science lab, or hospital knows poor storage ends up costing lives and money. Sadly, sometimes it takes losing an entire batch to teach a hard lesson about storing this stuff well.
Most antibiotics last longer and do a better job if they steer clear of moisture and sunlight. Streptomycin sulfate actually gets hit extra hard by those two enemies. Even the humidity in a warm room can start breaking it down long before an expiration date comes up. So, standard practice means a dry space, out of direct sun, in a tightly sealed container — think those thick amber bottles most hospitals use for medications.
Exposure to heat speeds up the process where antibiotics lose strength. Streptomycin sulfate does best at refrigerator temperatures, between 2°C and 8°C (36°F and 46°F). Once, in a small hospital in the tropics, the fridge failed. Staff had to toss the entire antibiotic supply, including a two-week supply of streptomycin. That sort of setback sets off a scramble and puts patients at risk.
Room temperature might work for short stretches, but nobody wins when medicine goes bad. Anyone responsible for medication storage should double-check fridge settings daily and make sure backup power kicks in, especially during storms or power outages. Those digital thermometers with alarms can save a world of trouble by catching temperature slips before the medicine suffers.
Security isn’t just nice-to-have. Antibiotics like streptomycin sulfate sometimes fall into the wrong hands. Diversion — where staff or outsiders swipe drugs for other uses — isn’t rare. Storing valuable medicines in a locked refrigerator within a monitored pharmacy or storeroom reduces that risk. Inventory logs and regular checks are part of the job at any hospital or pharmacy to make sure nothing “walks off.”
Mislabeled or expired medicine causes more harm than good. Always label containers with the date of receipt and preparation. It’s too easy to leave an old bottle on a high shelf and forget about it. Marking the expiration date up front reminds staff to use them before spoilage or potency loss. Sometimes, all it takes is a handful of sticky labels and a marker to avoid a thousand-dollar waste.
Many places trust staff training, but the truth is, distractions or staff turnover cause mistakes. Automation can help. Some hospitals use automated storage systems for antibiotics, where temperature and access are both controlled electronically. Investing in these systems pays back not just in drug safety but also in staff peace of mind. Pharmaceutical companies can also do more by including clear, readable storage instructions on packaging.
Antibiotic stewardship means protecting both the drug and those who rely on it. Proper, practical storage keeps life-saving medicine available precisely when it counts.
Streptomycin Sulfate belongs to a group of medicines known for tackling tough bacterial infections, especially tuberculosis and certain forms of plague and tularemia. Doctors everywhere trust this drug for cases that other antibiotics can’t seem to touch. This medication has earned its place in hospitals and clinics for over seven decades because it tends to work where other drugs hit a wall.
I remember growing up hearing family stories about tuberculosis, and it seemed almost like old news. Today, we still face TB and antibiotic resistance. Streptomycin often gets brought up as an answer when things turn serious. Yet side effects can’t be ignored. Every patient, especially those battling long-standing infections, deserves to know what they might face in a real-world way.
Hearing Loss and Balance ProblemsStreptomycin can target parts of the body beyond bacteria. For example, it often affects the inner ear. This might show up as ringing, dizziness, or trouble keeping your balance. In my own time working with health outreach, I’ve met folks who didn’t mention hearing trouble until it was almost impossible to miss. Hearing tests rarely happen outside major hospitals, so people from small towns or remote areas can get overlooked. Studies estimate that up to 15% of people on Streptomycin notice either hearing or balance changes. The issue gets worse when folks take the medicine for months or have kidney problems that stop the drug from leaving the body fast enough.
Kidney Stress and DamageThe kidneys filter out toxins. Streptomycin puts a lot of pressure on these organs. If the dose gets too high or kidneys already struggle, this pressure leads to damage. Blood tests can help, but they require follow-up, consistent care, and a well-informed doctor or health worker. Research published in journals like 'The Lancet' has shown a clear link between aminoglycosides (the group Streptomycin comes from) and kidney trouble, especially among older adults and newborns.
Muscle Weakness and Breathing TroubleStreptomycin rarely affects nerves that connect to muscles, but if it does, people feel weak or have trouble catching their breath. This problem tends to pop up in people who already have nerve or muscle conditions or who combine Streptomycin with other drugs that affect nerves or muscles. In the clinic, I’ve seen it mostly in people with myasthenia gravis or other chronic neuromuscular illnesses.
Other Common ComplaintsNausea, rash, fever, and pain at the injection site pop up in clinic charts fairly often. While not as permanent as hearing loss, these side effects can make life pretty miserable during the weeks or months someone takes Streptomycin. Especially for folks already fighting tough infections, these mid-level problems stack up.
Taking charge means knowing the risks. Hearing checks before and during treatment matter. Simple urine or blood tests help catch kidney issues before real damage sets in. Spreading this information matters most in communities with barriers to health care. If relatives, caregivers, or patients see new symptoms, especially around hearing, balance, or urination, flagging them early can make a difference. Doctors might need to adjust the dose, pause treatment, or swap in other drugs.
Streptomycin plays a critical role against dangerous infections, but nobody deserves to choose between life and long-term disability. Open conversations between patients and care teams, practical tools like checklists and reminders, and community awareness make it possible to catch problems early and help more people get better without lasting harm.
People usually reach for Streptomycin Sulfate to fight tough bacterial infections, especially when other options don’t work. But this antibiotic isn’t something to eyeball or self-prescribe. Doctors usually rely on tried-and-true guidelines and their clinical experience, and the recommended dose changes based on what’s being treated.
For adults battling tuberculosis, which is one of the main reasons Streptomycin Sulfate still gets prescribed, a typical recommendation falls between 15 mg per kilogram of body weight given daily, not exceeding 1 gram in a day. For children, most doctors stick to 20-40 mg per kilogram daily, up to 1 gram. Some situations call for larger or smaller doses—it depends on kidney health, age, weight, and the infection type.
In my time working alongside pharmacists and infectious diseases teams, I’ve seen the value of sticking to these limits. Too much streptomycin ramps up the chance of side effects without getting infections under control any faster. And this drug isn’t gentle on the ears or kidneys. That reality means doctors pay attention to kidney tests and, if needed, adjust the schedule from every day to two or three times a week.
Some people think more medicine means better results, but I’ve seen how overdoing it with streptomycin puts hearing and balance at risk—ototoxicity is real. Folks have lost hearing permanently, and it shows just how unforgiving this medication can be. People with poor kidney function face higher risks, and measuring blood levels in the hospital sometimes becomes the safest approach.
For people with normal kidneys, sticking to the standard daily dose keeps things in the safe zone most of the time. But once kidney problems show up, dosing must change to every 48 or even every 72 hours, and scheduled lab checks help keep everything in check.
No one should start this antibiotic without a clear diagnosis and a plan to follow up. Public health organizations, including the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), have shaped guidelines over decades. For example, tuberculosis regimens almost always include other antibiotics, and the prescriber uses Streptomycin Sulfate only for drug-resistant TB or rare cases of intolerance to other drugs.
Taking Streptomycin Sulfate by mouth doesn’t work—it's always given by injection, usually deep into muscle. For patients, that means health workers need to track symptoms, watch for early signs of ear problems or changes in urination, and send for blood tests if anything looks off.
Too often, crowded clinical settings miss early signs of trouble. Nurses who ask about ringing in the ears, sudden dizziness, or trouble balancing pick up on issues before they become permanent. Better systems for monitoring kidney function and hearing could save patients from long-term complications. Simple checklists and digital alerts now help catch red flags. More thorough patient counseling about possible side effects goes a long way.
With a clear view of how a specific patient’s health stacks up, and with close monitoring, Streptomycin Sulfate keeps its place as a valuable line of defense. The key: well-adjusted doses, regular lab-tests, and honest conversations about risks.
Streptomycin sulfate isn’t one of those flashy, new medications. It’s been treating tough infections like tuberculosis since the 1940s. Lately, I’ve seen more people asking about drug interactions, and for good reason. Mixing medicines brings the risk of unexpected problems. Nobody who’s already sick wants something new to worry about.
Few people take just one medication. Older adults, especially, often end up juggling scripts for blood pressure, diabetes, arthritis, you name it. Toss in an antibiotic like streptomycin, and you can imagine the confusion if there’s a clash. The most serious concern with streptomycin is its ability to cause damage to the kidneys and nerves. If another drug makes those side effects worse, you could be looking at some real trouble.
Doctors have known for years that combining streptomycin with other “aminoglycoside” antibiotics — gentamicin or tobramycin, for instance — raises the stakes. Similar drugs pack a similar punch, and their harmful effects on nerves and kidneys can stack up. It’s the same story with some water pills, or diuretics, used to lower blood pressure. Furosemide and ethacrynic acid are both notorious for worsening hearing loss and kidney issues when given with streptomycin.
In some cases, problems don’t show up right away. Some folks only notice trouble after reporting hearing loss, feeling off-balance, or struggling with weak muscles. I’ve seen a few patients where the signs were subtle and only noticed after several weeks. Most don’t realize that medications could be feeding off each other, quietly building up harm in the background.
The National Institutes of Health and the World Health Organization flag streptomycin as a drug with “notable nephrotoxicity and ototoxicity.” What stands out in research is the possibility of cumulative damage. Drug guides list the big threats: neuromuscular blockers (like pancuronium), and some anesthesia drugs can boost the risk of muscle weakness and breathing troubles. For anyone needing an operation, their medical team checks for these dangers early.
There’s one more category that comes up a lot: drugs that slow down excretion through the kidneys. Probenecid, for example, can trap streptomycin in the body longer, making side effects more likely. These aren’t obscure theoretical risks. The FDA, CDC, and international tuberculosis guidelines all spell them out.
Doctors, pharmacists, and nurses catch a lot of interactions, but nobody’s perfect — especially with new drugs on the worksheet every year. A family member once had to switch antibiotics halfway through treatment because her diuretic and her infection didn’t play nice with each other. The pharmacist caught it, not the doctor. That’s why double-checking every medication combo matters so much.
Pharmacists have software that hunts for red flags, and regular blood tests can spot kidney problems before symptoms get severe. I always recommend asking the pharmacist about every new prescription, even the ones that seem routine. Bring a full med list on each visit. If anything feels off — new weakness, trouble hearing, nausea — let your care team know right away.
Mixing drugs like streptomycin is a high-stakes game because the risks don’t always show up quickly and can linger even after stopping medications. Open communication, careful tracking, and patient involvement keep things safer.
| Names | |
| Preferred IUPAC name | Streptomycin sulfate |
| Other names |
Sulfate de Stréptomycine Streptomycinum sulfuricum Streptomycini sulfas Streptomycin sulfate Streptomycine sulfate Streptomycin Sulphate |
| Pronunciation | /strɛpˌtoʊˈmaɪ.sɪn ˈsʌl.feɪt/ |
| Preferred IUPAC name | Streptomycin sulfate |
| Other names |
Streptomycin sulfate Streptomycini sulfas Streptomycin hemisulfate Streptomycinsulfat Streptomycinum sulfuricum |
| Pronunciation | /strɛpˌtoʊˈmaɪsɪn ˈsʌl.feɪt/ |
| Identifiers | |
| CAS Number | 3810-74-0 |
| Beilstein Reference | 3913346 |
| ChEBI | CHEBI:9206 |
| ChEMBL | CHEMBL1200898 |
| ChemSpider | 13657486 |
| DrugBank | DB01082 |
| ECHA InfoCard | 100.031.712 |
| EC Number | 2.7.7.48 |
| Gmelin Reference | 117166 |
| KEGG | C00455 |
| MeSH | D013296 |
| PubChem CID | 63109 |
| RTECS number | WI2230000 |
| UNII | F6F0HK1URN |
| UN number | UN3249 |
| CompTox Dashboard (EPA) | DTXSID6043906 |
| CAS Number | 3810-74-0 |
| Beilstein Reference | 3736749 |
| ChEBI | CHEBI:9206 |
| ChEMBL | CHEMBL1200899 |
| ChemSpider | 55169 |
| DrugBank | DB01082 |
| ECHA InfoCard | 100.008.036 |
| EC Number | 2.7.7.48 |
| Gmelin Reference | 37721 |
| KEGG | C00432 |
| MeSH | D013287 |
| PubChem CID | 6536309 |
| RTECS number | WK7800000 |
| UNII | G93A29M9VH |
| UN number | UN3249 |
| CompTox Dashboard (EPA) | DTXSID3028595 |
| Properties | |
| Chemical formula | (C21H39N7O12)2·3H2SO4 |
| Molar mass | 1457.38 g/mol |
| Appearance | White or almost white, crystalline powder |
| Odor | Odorless |
| Density | Density: 1.27 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -6.4 |
| Acidity (pKa) | 10.5 |
| Basicity (pKb) | 7.7 |
| Magnetic susceptibility (χ) | -9.6×10⁻⁶ cm³/mol |
| Dipole moment | 0.00 D |
| Chemical formula | (C21H39N7O12)2·3H2SO4 |
| Molar mass | 1457.38 g/mol |
| Appearance | White or almost white, crystalline powder |
| Odor | Odorless |
| Density | Density: 1.28 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -6.3 |
| Acidity (pKa) | 7.2 |
| Basicity (pKb) | 5.25 |
| Magnetic susceptibility (χ) | -13.0×10⁻⁶ cm³/mol |
| Dipole moment | 0.00 D |
| Pharmacology | |
| ATC code | J01GA01 |
| ATC code | J01GA01 |
| Hazards | |
| Main hazards | May be fatal if swallowed, inhaled, or absorbed through skin. Causes eye, skin, and respiratory tract irritation. May cause allergic reactions. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07, GHS08 |
| Signal word | Danger |
| Hazard statements | H302: Harmful if swallowed. H317: May cause an allergic skin reaction. H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary statements | Precautionary statements: P261, P264, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362+P364, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 0, Instability: 0, Special: - |
| Autoignition temperature | > 410 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 5 g/kg |
| LD50 (median dose) | LD50 (oral, mouse): 4300 mg/kg |
| NIOSH | WQ0525000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Streptomycin Sulfate: "0.1 mg/m³ (OSHA as respirable dust) |
| REL (Recommended) | 25-50 mg/kg |
| IDLH (Immediate danger) | IDLH: 1000 mg/m³ |
| Main hazards | May cause allergy or asthma symptoms or breathing difficulties if inhaled; may cause an allergic skin reaction. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | Harmful if swallowed. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. Suspected of damaging fertility or the unborn child. |
| Precautionary statements | P261, P264, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P333+P313, P363, P337+P313, P405, P501 |
| NFPA 704 (fire diamond) | NFPA 704: 2-1-0 |
| Lethal dose or concentration | LD50 (oral, rat): 5,000 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 5 g/kg |
| NIOSH | RS1410000 |
| PEL (Permissible) | PEL = 5 mg/m³ |
| REL (Recommended) | 25 mg/kg once daily |
| IDLH (Immediate danger) | IDLH: 100 mg/m³ |
| Related compounds | |
| Related compounds |
Streptomycin Dihydrostreptomycin Streptidine Neomycin Kanamycin Gentamicin |
| Related compounds |
Streptidine Streptobiosamine Dihydrostreptomycin Neomycin Paromomycin Gentamicin |